S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Scott E. Smith, MD, PhD, FACP
Loyola University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
- Reid Hospital & Health Care Services, Incorporated
Richmond, Indiana, United States
- Cancer Center of Kansas, Pa - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas, Pa - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas, Pa - El Dorado
El Dorado, Kansas, United States
- Cancer Center of Kansas, Pa - Kingman
Kingman, Kansas, United States
- Southwest Medical Center
Liberal, Kansas, United States
- Cancer Center of Kansas, Pa - Newton
Newton, Kansas, United States
- Cancer Center of Kansas, Pa - Parsons
Parsons, Kansas, United States
- Cancer Center of Kansas, Pa - Pratt
Pratt, Kansas, United States
- Cancer Center of Kansas, Pa - Salina
Salina, Kansas, United States
- Cancer Center of Kansas, Pa - Wellington
Wellington, Kansas, United States
- Associates in Womens Health, Pa - North Review
Wichita, Kansas, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Medical Arts Tower
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Wichita
Wichita, Kansas, United States
- Via Christi Cancer Center at Via Christi Regional Medical Center
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Winfield
Winfield, Kansas, United States
- Highland Hospital of Rochester
Rochester, New York, United States
- Interlakes Oncology/hematology Pc
Rochester, New York, United States
- James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, United States
- Ccop - Dayton
Dayton, Ohio, United States
- David L. Rike Cancer Center at Miami Valley Hospital
Dayton, Ohio, United States
- Good Samaritan Hospital
Dayton, Ohio, United States
- Grandview Hospital
Dayton, Ohio, United States
- Veterans Affairs Medical Center - Dayton
Dayton, Ohio, United States
- Blanchard Valley Medical Associates
Findlay, Ohio, United States
- Charles F. Kettering Memorial Hospital
Kettering, Ohio, United States
- Middletown Regional Hospital
Middletown, Ohio, United States
- Uvmc Cancer Care Center at Upper Valley Medical Center
Troy, Ohio, United States
- United States Air Force Medical Center - Wright-Patterson
Wright-Patterson AFB, Ohio, United States
- Ruth G. Mcmillan Cancer Center at Greene Memorial Hospital
Xenia, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2005
- Primary completion
- 31 Jan 2008
- Completion
- 31 Dec 2011
- Last update posted
- 3 Apr 2012
- Registered enrollment
- 1
- Registry id
- NCT00121186
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.